Literature DB >> 20627295

Dehydroepiandrosterone sulfate is inversely associated with sex-dependent diverse carotid atherosclerosis regardless of endothelial function.

Sumiko Yoshida1, Ken-ichi Aihara, Hiroyuki Azuma, Ryoko Uemoto, Yuka Sumitomo-Ueda, Shusuke Yagi, Yasumasa Ikeda, Takashi Iwase, Susumu Nishio, Hiromi Kawano, Junko Miki, Hirotsugu Yamada, Yoichiro Hirata, Masashi Akaike, Masataka Sata, Toshio Matsumoto.   

Abstract

BACKGROUND: Dehydroepiandrosterone sulfate (DHEAS) is thought to be associated with life expectancy and anti-aging. However, its biological significance in atherosclerosis remains controversial. Therefore, the aim of this study was to determine whether DHEAS is associated with development of carotid atherosclerosis in subjects with cardiovascular risk factors. SUBJECTS AND METHODS: A total of 419 Japanese individuals (208 males and 211 females) were recruited from Tokushima University Hospital, Japan. In all subjects, maximum intima-media thickness (max-IMT) in all carotid arteries, and mean-IMT and mean blood flow volume (BFV) in the common carotid arteries (CCA) were measured by ultrasonography; endothelial function was assessed by flow-mediated vasodilation of the brachial artery (%FMD). Serum DHEAS and classical cardiovascular risk factors were also evaluated. Statistical significance was determined by multiple regression analysis to elucidate independent determinants of max-IMT, mean-IMT, mean CCA-BFV, and %FMD.
RESULTS: Serum DHEAS levels were higher in males than in females. Multiple regression analysis revealed that DHEAS was an independent negative factor for both max-IMT and mean-IMT in males but not in females. In contrast, DHEAS was the sole positive factor for mean CCA-BFV in females but not in males. In addition, there was no significant relationship between %FMD and DHEAS regardless of sex and other confounding factors.
CONCLUSION: Although DHEAS is not involved in endothelial function, DHEAS is inversely associated with sex-dependent diverse carotid atherosclerosis such as increased max-IMT and mean-IMT in males and decreased CCA-BFV in females. Copyright 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20627295     DOI: 10.1016/j.atherosclerosis.2010.05.011

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  13 in total

1.  Dehydroepiandrosterone suppresses eosinophil infiltration and airway hyperresponsiveness via modulation of chemokines and Th2 cytokines in ovalbumin-sensitized mice.

Authors:  Chian-Jiun Liou; Wen-Chung Huang
Journal:  J Clin Immunol       Date:  2011-06-04       Impact factor: 8.317

2.  Low dehydroepiandrosterone sulfate is associated with increased risk of ischemic stroke among women.

Authors:  Monik C Jiménez; Qi Sun; Markus Schürks; Stephanie Chiuve; Frank B Hu; Joann E Manson; Kathryn M Rexrode
Journal:  Stroke       Date:  2013-05-23       Impact factor: 7.914

Review 3.  Pharmacology of Aldosterone and the Effects of Mineralocorticoid Receptor Blockade on Cardiovascular Systems.

Authors:  Shusuke Yagi; Masashi Akaike; Ken-Ichi Aihara; Daiju Fukuda; Masayoshi Ishida; Takayuki Ise; Toshiyuki Niki; Yuka Sumitomo-Ueda; Koji Yamaguchi; Takashi Iwase; Yoshio Taketani; Hirotsugu Yamada; Takeshi Soeki; Tetsuzo Wakatsuki; Michio Shimabukuro; Masataka Sata
Journal:  Acta Cardiol Sin       Date:  2013-05       Impact factor: 2.672

4.  Androgen receptor promotes sex-independent angiogenesis in response to ischemia and is required for activation of vascular endothelial growth factor receptor signaling.

Authors:  Sumiko Yoshida; Ken-Ichi Aihara; Yasumasa Ikeda; Yuka Sumitomo-Ueda; Ryoko Uemoto; Kazue Ishikawa; Takayuki Ise; Shusuke Yagi; Takashi Iwase; Yasuhiro Mouri; Matomo Sakari; Takahiro Matsumoto; Ken-Ichi Takeyama; Masashi Akaike; Mitsuru Matsumoto; Masataka Sata; Kenneth Walsh; Shigeaki Kato; Toshio Matsumoto
Journal:  Circulation       Date:  2013-05-30       Impact factor: 29.690

Review 5.  Dehydroepiandrosterone on metabolism and the cardiovascular system in the postmenopausal period.

Authors:  Caio Jordão Teixeira; Katherine Veras; Carla Roberta de Oliveira Carvalho
Journal:  J Mol Med (Berl)       Date:  2019-11-12       Impact factor: 4.599

Review 6.  A review of age-related dehydroepiandrosterone decline and its association with well-known geriatric syndromes: is treatment beneficial?

Authors:  Nikolaos Samaras; Dimitrios Samaras; Emilia Frangos; Alexandre Forster; Jacques Philippe
Journal:  Rejuvenation Res       Date:  2013-08       Impact factor: 4.663

Review 7.  In vivo and in vitro evidences of dehydroepiandrosterone protective role on the cardiovascular system.

Authors:  Tiphaine Mannic; Joanna Viguie; Michel Florian Rossier
Journal:  Int J Endocrinol Metab       Date:  2015-04-30

8.  Impact of Hemorheology Assessed by the Microchannel Method on Pulsatility Index of the Common Carotid Artery in Patients With Type 2 Diabetes Mellitus.

Authors:  Takashi Hitsumoto
Journal:  J Clin Med Res       Date:  2017-05-22

9.  In vitro and in vivo tenocyte-protective effectiveness of dehydroepiandrosterone against high glucose-induced oxidative stress.

Authors:  Shintaro Mukohara; Yutaka Mifune; Atsuyuki Inui; Hanako Nishimoto; Takashi Kurosawa; Kohei Yamaura; Tomoya Yoshikawa; Ryosuke Kuroda
Journal:  BMC Musculoskelet Disord       Date:  2021-06-05       Impact factor: 2.362

Review 10.  Off-label use of hormones as an antiaging strategy: a review.

Authors:  Nikolaos Samaras; Maria-Aikaterini Papadopoulou; Dimitrios Samaras; Filippo Ongaro
Journal:  Clin Interv Aging       Date:  2014-07-23       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.